Every AI drug discovery deal, sourced.
2026incl. longevity
Funding rounds and pharma partnerships in AI-driven drug discovery, with the real upfront cash behind the headline numbers.
- Every deal links to the company's own announcement or a filing
- Checked for new deals every day
- Free to browse, free to download as CSV
Coming soon
The weekly aibiodeals brief
New rounds, new pharma deals, and how much is really paid up front. One email a week.
Signups aren't open yet. The newsletter launches soon.53deals tracked
47funding rounds
$4.42Bdisclosed venture capital
6pharma partnerships
Disclosed funding by month
Sum of disclosed AI drug discovery rounds, 2026
Rounds with undisclosed amounts are excluded. Rounds dated to a month only are counted in that month.Upfront vs. milestones
Only $263.0M of $8.58B in headline partnership value (3.1%) is paid up front.upfrontmilestones
Insilico Medicine × Eli Lilly · $115.0M of $2.75B
Insilico Medicine × SK Biopharmaceuticals · $18.0M of $2.50B
insitro × AstraZeneca · $40.0M of $1.50B
Generate Biomedicines × Zealand Pharma · $30.0M of $1.23B
Insilico Medicine × Takeda · $60.0M of $600.0M
Sponsor slot · Presented by
This space is available. Reach founders, investors and BD teams in AI drug discovery.Latest deals
- 15 Oct 2026insitro Partnership (research collab)
AstraZeneca$1.50BSource - 13 Oct 2026Generate Biomedicines Partnership (collab + license)
Zealand Pharma$1.23BSource - 3 Sep 2026AIPher Angel
Xiang He Capital (lead); Xinglian Capital$14.0MSource - 3 Sep 2026Superluminal Medicines Series B
BVF Partners (lead)$60.0MSource - 11 Aug 2026Axiom Therapeutics Private offering (Form D)
Investors not disclosed$12.3MSource - 10 Aug 2026Aureka Biotechnologies Series B
Granite Asia; HighLight Capital; MPCi; NRL Capital$100.0MSource - 10 Aug 2026Engine Biosciences Series B extension
GV$5.0MSource - 22 Jul 2026Transcripta Bio Post-Series A financing
Mayo Clinic; Omnimed; JAZZ Venture Partners; BlueYard Capital$24.0MSource - 17 Jul 2026Sightera Biosciences Pre-seed
Investors not disclosed$3.4MSource - 14 Jul 2026Chai Discovery Series C
Index Ventures (lead); Kleiner Perkins; Sequoia Capital; Dimension; Thrive Capital; OpenAI$400.0MSource